1.° Ars judiciaria secundùm novem Judices : authore anonymo. — 2.° Anonymi liber de inundatione Nili. — 3.° Anonymi liber de coloribus. — 4.° Anonymi liber de bona fortuna. — 5.° Anonymi libellus de lineis invisibilibus. — 6.° Liber de morte Aristotelis. — 7.° Liber de intelligentia Aristotelis. — 8.° Liber de causa motûs animalium. — 9.° Liber de juventute et senectute. — 10.° Liber de respiratione. — 11.° Aristotelis liber de morte et vita.

Colbertinus

Implantació de l'administració electrònica als ajuntaments

Aquesta memòria descriu com la llei 11/2007 de 22 de juny, d’accés electrònic dels ciutadans als serveis públics, és el punt de partida de la transformació de les administracions públiques, entre elles els ajuntaments, cap a l’administració electrònica. La implantació del projecte descrit s’ha portat a terme amb la perspectiva que la simplificació, normalització i homogeneïtzació dels processos administratius ha de ser el primer pas a realitzar. Posteriorment hem d’ajudar a l’ajuntament a avançar cap al seu propi model d’administració electrònica i, assolir així, els objectius de millorar la gestió interna i prestar un servei òptim i de qualitat a la ciutadania. Finalment hem d’establir un sistema que permeti realitzar el seguiment i avaluació de les actuacions vinculades a l’Administració Electrònica implantada que ens permetrà, a l’equip de treball, adequar i reajustar l’estratègia de l’ajuntament als objectius establerts, trobant eixos de millora i legitimant la presa de decisió.

1-11-19, Toussaint au cimetière de Bagneux [cénotaphe à la mémoire des soldats morts pour la France] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56740

5-11-19, M. Clemenceau dans le port de Kehl : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56814

Colombe, 9/11/19, rugby, équipe [de] Périgueux [i. e. le C. A. Périgourdin qui a été battu par le Racing Club de France] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56861

5-11-19, M. Clemenceau arrivant au fort de Kirchbach : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56810

5-11-19, [M. Clemenceau] dans le port de Kehl : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56813

Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil

Candida species are an important cause of bloodstream infections (BSI). To evaluate the epidemiological, clinical and microbiological aspects of two cohorts {1994-1999 [period 1 (P1) ]; 2000-2004 [period 2 (P2) ]} of candidaemic patients, we performed a retrospective analysis from a laboratory-based survey. A total of 388 candidaemias were identified, with an incidence of 0.20/1,000 patient-days and a significant increase in P2 vs. P1 (0.25 vs. 0.15, p = 0.04). Cancer and prior antibiotic use were frequent and Candida albicans was the most prevalent species found (42.4%). Resistance to fluconazole was found in 2.47% of the strains. No differences were observed in the species distribution of Candida during the study periods. In the P2 cohort, there were higher prevalence of elderly individuals, cardiac, pulmonary and liver diseases, renal failure, central venous catheters and antibiotic therapy. In P1, there were higher prevalence of neurological diseases and chemotherapy. The crude mortality was 55.4%. In conclusion, our incidence rates remained high. Furthermore, the distribution pattern of Candida species and the fluconazole resistance profile remained unchanged. Moreover, we found a clear trend of higher prevalence of candidaemia among the elderly and among patients with comorbidities. Finally, it is necessary to discuss strategies for the prevention and control of Candida BSI in Brazil.

Parc des Princes, 9/11/19, rugby, équipe du Stade Français [qui a battu l'équipe de Nantes] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56859

Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.

Since 2004, cannabis has been prohibited by the World Anti-Doping Agency for all sports competitions. In the years since then, about half of all positive doping cases in Switzerland have been related to cannabis consumption. In doping urine analysis, the target analyte is 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH), the cutoff being 15 ng/mL. However, the wide urinary detection window of the long-term metabolite of Delta(9)-tetrahydrocannabinol (THC) does not allow a conclusion to be drawn regarding the time of consumption or the impact on the physical performance. The purpose of the present study on light cannabis smokers was to evaluate target analytes with shorter urinary excretion times. Twelve male volunteers smoked a cannabis cigarette standardized to 70 mg THC per cigarette. Plasma and urine were collected up to 8 h and 11 days, respectively. Total THC, 11-hydroxy-Delta(9)-tetrahydrocannabinol (THC-OH), and THC-COOH were determined after hydrolysis followed by solid-phase extraction and gas chromatography/mass spectrometry. The limits of quantitation were 0.1-1.0 ng/mL. Eight puffs delivered a mean THC dose of 45 mg. Plasma levels of total THC, THC-OH, and THC-COOH were measured in the ranges 0.2-59.1, 0.1-3.9, and 0.4-16.4 ng/mL, respectively. Peak concentrations were observed at 5, 5-20, and 20-180 min. Urine levels were measured in the ranges 0.1-1.3, 0.1-14.4, and 0.5-38.2 ng/mL, peaking at 2, 2, and 6-24 h, respectively. The times of the last detectable levels were 2-8, 6-96, and 48-120 h. Besides high to very high THC-COOH levels (245 +/- 1,111 ng/mL), THC (3 +/- 8 ng/mL) and THC-OH (51 +/- 246 ng/mL) were found in 65 and 98% of cannabis-positive athletes' urine samples, respectively. In conclusion, in addition to THC-COOH, the pharmacologically active THC and THC-OH should be used as target analytes for doping urine analysis. In the case of light cannabis use, this may allow the estimation of more recent consumption, probably influencing performance during competitions. However, it is not possible to discriminate the intention of cannabis use, i.e., for recreational or doping purposes. Additionally, pharmacokinetic data of female volunteers are needed to interpret cannabis-positive doping cases of female athletes.